TransCode Therapeutics - SEC Filing
Por um escritor misterioso
Descrição
Technical Analysis of TransCode Therapeutics, Inc. (NASDAQ:RNAZ
RNAZ - Form SC 13D/A - General statement of acquisition of
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
SEC Filings - cyclotherapeutics
TransCode Therapeutics - SEC Filing
EDGAR Filing Documents for 0001104659-21-029169
Cass Information Systems reports Firs
RNAZ - TransCode Therapeutics Announces Pricing of $8 Million